Prehabilitation is feasible in patients with rectal cancer undergoing neoadjuvant chemoradiotherapy and may minimize physical deterioration: results from the REx trial.

Susan J MougN MutrieSarah J E BarryG MackayRobert James Campbell SteeleC BoachieC BuchanA S Anderson

Published in: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland (2019)

This study demonstrates that prehabilitation is feasible in rectal cancer patients undergoing NACRT. Good recruitment, adherence, retention and patient satisfaction rates support the development of a fully powered trial. The effects of the intervention on physical outcomes were promising.

Keyphrases

rectal cancer
locally advanced
patient satisfaction
patients undergoing
study protocol
phase iii
physical activity
mental health
randomized controlled trial
phase ii
clinical trial
squamous cell carcinoma
type diabetes
radiation therapy
adipose tissue
skeletal muscle
lymph node